Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | RGEN | Common Stock | Award | $0 | +3.47K | +18.79% | $0.00 | 21.9K | Mar 2, 2023 | Direct | F1 |
transaction | RGEN | Common Stock | Award | $0 | +3.59K | +16.38% | $0.00 | 25.5K | Mar 3, 2023 | Direct | F2 |
transaction | RGEN | Common Stock | Tax liability | -$234K | -1.25K | -4.89% | $188.00 | 24.3K | Mar 3, 2023 | Direct | F3 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | RGEN | Stock Option (Right to Buy) | Award | $0 | +3.59K | $0.00 | 3.59K | Mar 2, 2023 | Common Stock | 3.59K | $180.48 | Direct | F4 |
Id | Content |
---|---|
F1 | Mr. Kuriyel was awarded 3,468 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual instalments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. |
F2 | Represents 375 shares issued pursuant to a Performance Stock Unit ("PSU") award granted to the Issuer on January 1, 2022, and 3,216 shares issued pursuant to a PSU award granted to the Issuer on February 27, 2020. The Compensation Committee authorized the issuance of the underlying shares based upon the Issuer's achievement of pre-established performance criteria set forth in the PSU awards. |
F3 | Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the settlement of the PSUs. |
F4 | One third of the stock options will vest and become exercisable annually on March 2, 2024, March 2, 2025, and March 2, 2026. |